The report on the Global Bleeding Disorders Treatment Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Study period considered for research of global bleeding disorders treatment market:
- Base Year: 2019
- Estimated Year: 2020
- Forecast Till: 2026
A glimpse of the major drivers and restraints affecting the bleeding disorders treatment market is mentioned below:
Drivers
- Growing R&D investment for development of hemophilia products
- Growing preference for prophylactic treatment
- Rising number of diagnosed hemophilia patients
- Growing healthcare expenditure
Restraints
- High cost of hemophilia drugs
- Insufficient reimbursement
The report offers a value chain analysis that gives a comprehensive outlook of the bleeding disorders treatment market. The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.
The bleeding disorders treatment market has been segmented based on type such as hemophilia A, hemophilia B, von willebrand disease, and others. The study incorporates periodic market estimates and forecasts. Each type has been analyzed based on the market size at regional and country levels.
The bleeding disorders treatment market has been segmented based on drug class such as plasma-derived coagulation factor concentrates, recombinant coagulation factor concentrates, desmopressin, antifibrinolytics, fibrin sealants, and others. Plasma-derived coagulation factor concentrates (factor viii, factor ix, factor for von willebrand disease, activated prothrombin complex concentrate), and recombinant coagulation factor concentrates (factor viii, factor for von willebrand disease, factor IX). The report provides forecast and estimates for each drug class in terms of market size during the study period. Each drug class has been further analyzed based on regional and country levels.
Geographically, the bleeding disorders treatment market has been segmented into regions such as North America, Europe, Asia Pacific, and Rest of the World. The study details country-level aspects based on each segment and gives estimates in terms of market size.
The report also covers the complete competitive landscape of the global Bleeding Disorders Treatment market with company profiles of key players such as:
- Baxalta (Now Shire)
- Bayer Pharmaceuticals
- Novo Nordisk A/S
- Pfizer Inc.
- Biogen Idec
- CSL Behring
- Grifols
- Octapharma
A detailed description of each has been included, with information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments. This analysis gives a thorough idea about the competitive positioning of market players. The report also gives information of bleeding disorders treatment market’s mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
Bleeding Disorders Treatment Market Analysis by Type:
- Hemophilia A
- Hemophilia B
- Von Willebrand Disease
- Others
Bleeding Disorders Treatment Market Analysis by Drug Class:
- Plasma-derived Coagulation Factor Concentrates
- Factor VIII
- Factor IX
- Factor for Von Willebrand Disease
- Activated Prothrombin Complex Concentrate
- Recombinant Coagulation Factor Concentrates
- Factor VIII
- Factor for Von Willebrand Disease
- Factor IX
- Desmopressin
- Antifibrinolytics
- Fibrin Sealants
- Others
Bleeding Disorders Treatment Market Analysis by Geography:
- North America
- Europe
- Asia Pacific
- Rest of the World
The Global Bleeding Disorders Treatment Market has been exhibited in detail in the following chapters -
Chapter 1 Bleeding Disorders Treatment Market Preface
Chapter 2 Executive Summary
Chapter 3 Bleeding Disorders Treatment Industry Analysis
Chapter 4 Bleeding Disorders Treatment Market Value Chain Analysis
Chapter 5 Bleeding Disorders Treatment Market Analysis By Type
Chapter 6 Bleeding Disorders Treatment Market Analysis By Drug Class
Chapter 7 Bleeding Disorders Treatment Market Analysis By Geography
Chapter 8 Competitive Landscape Of Bleeding Disorders Treatment Companies
Chapter 9 Company Profiles Of Bleeding Disorders Treatment Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.